Literature DB >> 26109071

RasGAP Shields Akt from Deactivating Phosphatases in Fibroblast Growth Factor Signaling but Loses This Ability Once Cleaved by Caspase-3.

Katia Cailliau1, Arlette Lescuyer2, Anne-Françoise Burnol3, Álvaro Cuesta-Marbán4, Christian Widmann4, Edith Browaeys-Poly2.   

Abstract

Fibroblast growth factor receptors (FGFRs) are involved in proliferative and differentiation physiological responses. Deregulation of FGFR-mediated signaling involving the Ras/PI3K/Akt and the Ras/Raf/ERK MAPK pathways is causally involved in the development of several cancers. The caspase-3/p120 RasGAP module is a stress sensor switch. Under mild stress conditions, RasGAP is cleaved by caspase-3 at position 455. The resulting N-terminal fragment, called fragment N, stimulates anti-death signaling. When caspase-3 activity further increases, fragment N is cleaved at position 157. This generates a fragment, called N2, that no longer protects cells. Here, we investigated in Xenopus oocytes the impact of RasGAP and its fragments on FGF1-mediated signaling during G2/M cell cycle transition. RasGAP used its N-terminal Src homology 2 domain to bind FGFR once stimulated by FGF1, and this was necessary for the recruitment of Akt to the FGFR complex. Fragment N, which did not associate with the FGFR complex, favored FGF1-induced ERK stimulation, leading to accelerated G2/M transition. In contrast, fragment N2 bound the FGFR, and this inhibited mTORC2-dependent Akt Ser-473 phosphorylation and ERK2 phosphorylation but not phosphorylation of Akt on Thr-308. This also blocked cell cycle progression. Inhibition of Akt Ser-473 phosphorylation and entry into G2/M was relieved by PHLPP phosphatase inhibition. Hence, full-length RasGAP favors Akt activity by shielding it from deactivating phosphatases. This shielding was abrogated by fragment N2. These results highlight the role played by RasGAP in FGFR signaling and how graded stress intensities, by generating different RasGAP fragments, can positively or negatively impact this signaling.
© 2015 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  Akt PKB; GTPase-activating protein (GAP); Xenopus; caspase; cell signaling; fibroblast growth factor receptor (FGFR); mitogen-activated protein kinase (MAPK); oocyte; phosphatase; receptor tyrosine kinase

Mesh:

Substances:

Year:  2015        PMID: 26109071      PMCID: PMC4528130          DOI: 10.1074/jbc.M115.644633

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  69 in total

1.  ERK2 is required for FGF1-induced JNK1 phosphorylation in Xenopus oocyte expressing FGF receptor 1.

Authors:  Edith Browaeys-Poly; Véronique Fafeur; Jean Pierre Vilain; Katia Cailliau
Journal:  Biochim Biophys Acta       Date:  2005-03-22

2.  PHLPPing it off: phosphatases get in the Akt.

Authors:  Michelle C Mendoza; John Blenis
Journal:  Mol Cell       Date:  2007-03-23       Impact factor: 17.970

Review 3.  Fibroblast growth factor receptor inhibitors as a cancer treatment: from a biologic rationale to medical perspectives.

Authors:  Maria Vittoria Dieci; Monica Arnedos; Fabrice Andre; Jean Charles Soria
Journal:  Cancer Discov       Date:  2013-02-15       Impact factor: 39.397

4.  Mechanism of activation of protein kinase B by insulin and IGF-1.

Authors:  D R Alessi; M Andjelkovic; B Caudwell; P Cron; N Morrice; P Cohen; B A Hemmings
Journal:  EMBO J       Date:  1996-12-02       Impact factor: 11.598

5.  Expression of the FGFR1 gene in human breast-carcinoma cells.

Authors:  J Jacquemier; J Adelaide; P Parc; F Penault-Llorca; J Planche; O deLapeyriere; D Birnbaum
Journal:  Int J Cancer       Date:  1994-11-01       Impact factor: 7.396

6.  Role of the sub-cellular localization of RasGAP fragment N2 for its ability to sensitize cancer cells to genotoxin-induced apoptosis.

Authors:  Alessandro Annibaldi; David Michod; Linda Vanetta; Steeve Cruchet; Pascal Nicod; Gilles Dubuis; Christelle Bonvin; Christian Widmann
Journal:  Exp Cell Res       Date:  2009-03-27       Impact factor: 3.905

7.  Fragment N2, a caspase-3-generated RasGAP fragment, inhibits breast cancer metastatic progression.

Authors:  David Barras; Girieca Lorusso; Benoît Lhermitte; David Viertl; Curzio Rüegg; Christian Widmann
Journal:  Int J Cancer       Date:  2014-03-04       Impact factor: 7.396

8.  Ras GTPase-activating protein binds to Akt and is required for its activation.

Authors:  Yingzi Yue; Jaqueline Lypowy; Nadia Hedhli; Maha Abdellatif
Journal:  J Biol Chem       Date:  2004-01-05       Impact factor: 5.157

9.  mTORC2 protein complex-mediated Akt (Protein Kinase B) Serine 473 Phosphorylation is not required for Akt1 activity in human platelets [corrected].

Authors:  Samantha F Moore; Roger W Hunter; Ingeborg Hers
Journal:  J Biol Chem       Date:  2011-05-18       Impact factor: 5.157

10.  Solution structure of GAP SH3 domain by 1H NMR and spatial arrangement of essential Ras signaling-involved sequence.

Authors:  Y S Yang; C Garbay; M Duchesne; F Cornille; N Jullian; N Fromage; B Tocque; B P Roques
Journal:  EMBO J       Date:  1994-03-15       Impact factor: 11.598

View more
  3 in total

1.  Casein kinase 1 (CK1) promotes the proliferation and metastasis of glioma cells via the phosphatidylinositol 3 kinase-matrix metalloproteinase 2 (AKT-MMP2) pathway.

Authors:  Hua-Song Gao; She-Yu Lin; Xi Han; Hong-Zhi Xu; Yi-Lu Gao; Zhi-Yong Qin
Journal:  Ann Transl Med       Date:  2021-04

2.  Palmitoylated SCP1 is targeted to the plasma membrane and negatively regulates angiogenesis.

Authors:  Peng Liao; Weichao Wang; Yu Li; Rui Wang; Jiali Jin; Weijuan Pang; Yunfei Chen; Mingyue Shen; Xinbo Wang; Dongyang Jiang; Jinjiang Pang; Mingyao Liu; Xia Lin; Xin-Hua Feng; Ping Wang; Xin Ge
Journal:  Elife       Date:  2017-03-31       Impact factor: 8.140

Review 3.  Crosstalk of the Caspase Family and Mammalian Target of Rapamycin Signaling.

Authors:  Junfang Yan; Yi Xie; Jing Si; Lu Gan; Hongyan Li; Chao Sun; Cuixia Di; Jinhua Zhang; Guomin Huang; Xuetian Zhang; Hong Zhang
Journal:  Int J Mol Sci       Date:  2021-01-15       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.